Live Quote · NASDAQRVMDHealthcare· Biotechnology

Revolution Medicines, Inc.

$186.16▲ 3.90%(+$6.98)
TickerSpark Score
56/100
▌ Mixed
60
Valuation
20
Profitability
15
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RVMD research report →

52-Week Range95% of range
Low
$34.00
Current
$186.16
High
$193.82
Company Overviewwww.revmed.com

About the company

Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers.

CEO
Mark A. Goldsmith
IPO
2020
Employees
883
HQ
Redwood City, CA, US

Price Chart

+376.72% · this period
$192.62$113.66$34.70Jul 17Jan 15Jul 17

Get TickerSpark's AI analysis on RVMD

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in